rosiglitazone has been researched along with ucn 1028 c in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Evangelinos, N; Kaloyianni, M; Koliakos, G; Koutsogiannaki, S | 1 |
Cerny, LM; Rehan, VK; Sakurai, R; Torday, JS | 1 |
Bosco, AA; Mattos, RT; Nogueira-Machado, JA | 1 |
3 other study(ies) available for rosiglitazone and ucn 1028 c
Article | Year |
---|---|
Cytotoxic mechanisms of Zn2+ and Cd2+ involve Na+/H+ exchanger (NHE) activation by ROS.
Topics: Acetylcysteine; Amiloride; Animals; Antimycin A; Antioxidants; Cadmium; Cadmium Poisoning; Cell Survival; Gills; Hydrogen-Ion Concentration; Mytilus; Naphthalenes; Oxidants; PPAR gamma; Protein Kinase Inhibitors; Pyruvic Acid; Reactive Oxygen Species; Receptors, Adrenergic; Rosiglitazone; Rotenone; Sodium-Hydrogen Exchangers; Thiazolidinediones; Water Pollutants, Chemical; Zinc | 2006 |
Mechanism for nicotine-induced up-regulation of Wnt signaling in human alveolar interstitial fibroblasts.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Base Sequence; beta Catenin; Cell Line; Cell Transdifferentiation; DNA Primers; Fibroblasts; Humans; Naphthalenes; Nicotine; PPAR gamma; Protein Kinase C; Pulmonary Alveoli; Receptors, Nicotinic; Rosiglitazone; Signal Transduction; Thiazolidinediones; Up-Regulation; Wnt Proteins | 2011 |
Rosiglitazone, a PPAR-γ agonist, inhibits VEGF secretion by peripheral blood mononuclear cells and ROS production by human leukocytes.
Topics: Adult; Humans; Hypoglycemic Agents; Leukocytes; Leukocytes, Mononuclear; Luminescence; Middle Aged; Naphthalenes; Phorbol 12,13-Dibutyrate; PPAR gamma; Protein Kinase C; Reactive Oxygen Species; Rosiglitazone; Thiazolidinediones; Vascular Endothelial Growth Factor A | 2012 |